In addition, ROS is the key mediator in NALFD inflammation and apoptosis in NAFLD by upregulating the NF-κB, a master inflammatory transcription factor, and p53, a tumor suppressor gene that activates the p53/Bax apoptotic mitochondria pathway [48,50]. The gene discussed is TP53; the disease is metabolic dysfunction-associated steatotic liver disease.